首页> 外文期刊>BMC Pregnancy and Childbirth >Application of the BACs-on-Beads assay for the prenatal diagnosis of chromosomal abnormalities in Quanzhou, China
【24h】

Application of the BACs-on-Beads assay for the prenatal diagnosis of chromosomal abnormalities in Quanzhou, China

机译:BACS-on-eads测定在泉州泉州染色体异常产前诊断中的应用

获取原文
       

摘要

Abstract Background An increasing number of techniques have been used for prenatal diagnosis of genetic abnormalities. Our initial objective was to explore the value of the BACs-on-Beads (BoBs) assay for the prenatal diagnosis of aneuploidies and microdeletion/microduplication syndromes in Quanzhou, Southeast China. Methods A total of 1409 pregnant women with high-risk factors for chromosomal abnormalities admitted to Quanzhou Women’s and Children’s Hospital were enrolled in this study. BoBs assays and karyotype analyses were conducted for all subjects. Subsequently, chromosome microarray analysis (CMA) or fluorescence in situ hybridization (FISH) was performed to validate the findings. Results In this study, karyotype analysis and BoBs assay failed in 4 cases, and 2 cases, respectively. A total of 1403 cases were successfully analyzed, with success rates of 99.72% (1405/1409) and 99.85% (1407/1409) for karyotype analysis and Bobs assay, respectively. BoBs assay rapidly detected chromosomal aneuploidies in line with the karyotyping data. Additionally, 23 cases of microdeletions/microduplications were detected by BoBs assay but missed by karyotyping, including 22q11.2 microdeletions/microduplications, 5p15.32p15.33 microdeletion, Xp22.31 microdeletions/microduplications, Xq27.3 microdeletion, and Yp11.2 and Yq11.22q11.222 microduplication. In comparison with karyotyping, fewer mosaicisms were identified by BoBs assay. A high detection rate of chromosomal abnormalities was observed in the high-risk group during noninvasive prenatal testing (NIPT) (41.72%) and the abnormal ultrasound group (13.43%). Conclusions BoBs assay can be used for the rapid and efficient prenatal diagnosis of common aneuploidies and microdeletion/microduplication syndromes. Moreover, the combined use of BoBs assay and karyotyping in prenatal diagnosis may allow for a more effective detection of chromosomal abnormalities.
机译:摘要背景越来越多的技术已被用于遗传异常的产前诊断。我们的初步目的是探讨BACS-on-eads(BOB)测定的价值,用于泉州泉州,东南部的非燕果饼和微缺失/微综合证综合征的产前诊断。方法在本研究中注册了共有染色体异常的染色体异常的高风险因素的1409例孕妇。对所有受试者进行鲍勃测定和核型分析。随后,进行染色体微阵列分析(CMA)或原位杂交(鱼类)的荧光以验证调查结果。结果在本研究中,核型分析和鲍勃测定分别在4例中失败,2例分别。共有1403例成功分析,成功率为99.72%(1405/1409)和99.85%(1407/1409),分别用于核型分析和鲍勃斯测定。鲍勃斯测定迅速检测到核心单倍体与核型分类数据的染色体非流量倍增性。此外,鲍勃斯测定检测到23例微缺失/微扫描,但核型分型错过,包括22Q11.2微缺失/微扫描,5p15.32p15.33微缺失,XP22.31微缺失,XQ27.3微缺失和YP11.2和YP11.2 YQ11.22Q11.222微量杂本。与核型分析相比,鲍勃斯测定鉴定了更少的镶嵌物。在非侵入性产前检测(NIPT)(41.72%)和异常超声组(13.43%)期间,在高风险组中观察到染色体异常的高检测率。结论鲍勃测定可用于普通非血糖和微缺综合征的快速高效产前诊断。此外,鲍勃斯测定和核型分析在产前诊断中的结合使用可能允许更有效地检测染色体异常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号